ART. XXII.—The Dispensatory of the United States of America

Opioid formulations in development designed to curtail abuse: who is the target?

“…An irony is apparent in the newest goal of opioid developers: since the early days of pharmacy medicine, scientists have focused on extracting the purest form possible of pain-relieving morphine from the poppy plant [1] . Modern chemistry brought the development of potent synthetic derivatives.…”